GeneDx Holdings Corp. (WGS)
Health Care ยท Services-Health Services
GeneDx Holdings Corp. (WGS) is listed on Nasdaq, where its shares have traded since July 23, 2021. SentiSense covers GeneDx Holdings Corp. in the Health Care sector, and its Standard Industrial Classification is Services-Health Services. Katherine Stueland is its chief executive officer. The company reports 1,300 employees, and its corporate website is www.genedx.com.
About GeneDx Holdings Corp.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
Latest reported results
GeneDx Holdings Corp. reported revenue of $114.4 million for Q2 FY2026, up 11.4% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 218 institutions reported holding WGS, with 31.6 million shares worth $2.2 billion in aggregate. The largest reported holders were Corvex Management, Casdin Capital and BlackRock. Of the 5 largest reported holders, all 5 added shares during the quarter.
More on WGS
- WGS sentiment: whether news and social coverage of GeneDx Holdings Corp. leans bullish or bearish, and the stories driving it.
- WGS ownership: all 218 reporting institutions, plus insider and congressional trades.
- WGS financials: revenue, net income, operating margin and free cash flow through Q2 FY2026.
Frequently asked questions
What does GeneDx Holdings Corp. do?
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders.
What sector is WGS in?
SentiSense classifies GeneDx Holdings Corp. in the Health Care sector, and its Standard Industrial Classification is Services-Health Services.
Where does WGS stock trade?
GeneDx Holdings Corp. (WGS) is listed on Nasdaq, where its shares have traded since July 23, 2021.
Who is the CEO of GeneDx Holdings Corp.?
Katherine Stueland is the chief executive officer of GeneDx Holdings Corp..